March 3 Mar 3
2020
Tuesday Tue
Event

4th Annual CDCM Symposium

REGISTER NOW!

The CDCM is a joint initiative of the Stanford University School of Medicine, Stanford Health Care and Stanford Children’s Health. The Center provides the organizational and physical infrastructure to support investigator-initiated clinical translational studies on stem cell and gene therapy from initial discovery through completion of clinical proof-of-concept studies. 

This scientific conference will bring together clinicians, basic scientists, patient advocates, translational investigators and experts from the biotech/pharmaceutical field to discuss the process of how discoveries in gene and cell therapy are translated to clinical trials and ultimately commercialized.

PROGRAM

7:30-8:00am

Breakfast

8:00-8:15am

Opening Remarks

8:15-8:20am

Welcome: Maria Grazia Roncarolo, MD, Director, CDCM, Stanford University

Opening Keynote

8:20-9:10am

 

Introduction of Keynote: Matthew Porteus, MD, PhD, Co-Director, CDCM, Stanford University

Keynote: Luigi Naldini, MD, PhD, Director, San Raffaele Telethon Institute for Gene Therapy

 

 

Session 1: New Cell-Based Medicine Discoveries                                                                                       

Moderator: Fraser Wright, PhD, Professor of Pediatrics, CDCM

9:10-9:35am

Philip Beachy, PhD, The Ernest and Amelia Gallo Professor in the School of Medicine, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology, Stanford University

9:35-10:00am

Charles Kwok Fai Chan, PhD, Assistant Professor of Surgery (Plastic & Reconstructive Surgery), Stanford University

Regulation of Cell and Gene Therapy

10:00-10:30am

Introduction: Bruce Burnett, PhD, Interim Executive Director, LCGM, Stanford University

Elizabeth Hart, MD, Office of Tissues and Advanced Therapies, CBER, FDA

10:30-11:00am

BREAK

Session 2: Pre-Clinical Development of Curative Medicines                                                                       

Moderator: Mary Leonard, M.D., M.S.C.E.

11:00-11:25am

Anthony Oro, MD, PhD, Co-Director, CDCM, Stanford University

11:25-11:50am

Bertha Chen, MD, Professor of Obstetrics and Gynecology (Gynecology - Urogynecology) and, by courtesy, of Urology at the Stanford University Medical Center

Models of Academic/Private Collaboration

11:50-12:30pm

Introduction: Devan Shah, Director of Business Development, CDCM, Stanford University

Steven M. Altschuler, MD, Managing Director, Healthcare Ventures, at Ziff Capital Partners

12:30-1:30pm

LUNCH

Session 3: Clinical Trials in Curative Medicines

 Moderator: Natalia Gomez-Ospina, MD, PhD

1:30-1:55pm

Thomas Rando, MD, PhD, Professor, Neurology & Neurological Sciences, Stanford University

1:55-2:20pm

Kara Lynn Davis, DO, Assistant Professor, Hematology/Oncology, Stanford University

Manufacturing of Cell and Gene Therapies

2:20-3:00pm

Introduction: Irv Weissman, MD, Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University

Stefan Miltenyi, President, Miltenyi Biotec Inc.

3:00-3:30pm

BREAK

Physician Advocacy for Patients

3:30-4:00pm

Introduction: Matthew Porteus, MD, PhD, Co-Director, CDCM, Stanford

Wanda Whitten-Shurney, MD, CEO and Medical Director, Sickle Cell Disease Association of America (SCDAA)

Closing Keynote:

4:00-4:45pm

Introduction of Keynote: Anthony Oro, MD, PhD, Co-Director, CDCM, Stanford

Keynote: Gordon Keller, PhD, Scientific Co-Founder of BlueRock Therapeutics and Director of the McEwen Centre for Regenerative Medicine at University of Health Network, Toronto

4:45-4:50pm

Closing Remarks: Maria Grazia Roncarolo, MD, Director, CDCM, Stanford

5:00-6:00pm

WINE & CHEESE RECEPTION